Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ironwood Pharmaceuticals Inc IRWD

Healthcare Biotechnology
Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company engaged in advancing the treatment of GI diseases and redefining the standard of care for GI patients. It is engaged in the development of LINZESS (linaclotide) for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Linaclotide is also approved for the treatment of... see more

Recent & Breaking News (NDAQ:IRWD)

Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference

Business Wire January 2, 2018

Ironwood Pharmaceuticals Initiates Phase II Clinical Trial of sGC Stimulator IW-1701 in Patients with Sickle Cell Disease

Business Wire December 21, 2017

Ironwood Reports Top-line Phase IIa Data for IW-1973 Demonstrating Positive Cardiovascular, Metabolic and Endothelial Effects

Business Wire December 4, 2017

Ironwood Pharmaceuticals Strengthens Executive Leadership Team

Business Wire November 28, 2017

Market Trends Toward New Normal in Public Service Enterprise Group, Rigel Pharma, National Oilwell Varco, Ironwood Pharma, Express Scripts, and Synergy Pharma – Emerging Consolidated Expectations, Analyst Ratings

GlobeNewswire November 6, 2017

Ironwood Pharmaceuticals Provides Third Quarter 2017 Investor Update

Business Wire November 2, 2017

Ironwood Pharmaceuticals to Present at Credit Suisse 26th Annual Healthcare Conference

Business Wire November 1, 2017

Ironwood Highlights Breadth of Gout Research to be Presented at the 2017 ACR/ARHP Annual Meeting

Business Wire October 30, 2017

Daily Technical Summary Reports on Generic Drugs Stocks -- Ironwood Pharma, Mylan, Neurocrine Biosciences, and Versartis

PR Newswire October 27, 2017

Ironwood Pharmaceuticals to Host Third Quarter 2017 Investor Update Call

Business Wire October 19, 2017

Ironwood Pharmaceuticals Presenting Linaclotide Data at the World Congress of Gastroenterology at ACG 2017

Business Wire October 16, 2017

Ironwood Pharmaceuticals Announces Leadership Change

Business Wire September 6, 2017

Ironwood Pharmaceuticals to Present at Upcoming September Investor Conferences

Business Wire August 31, 2017

Generic Drugs Stock Performance Review -- Patheon, Zoetis, Ironwood Pharma, and Medicines Co.

PR Newswire August 21, 2017

Watch These 7 Huge Put Purchases In Friday Trade

Benzinga.com  August 4, 2017

Ironwood Pharmaceuticals Provides Second Quarter 2017 Investor Update

Business Wire August 3, 2017

Investor Network: Ironwood Pharmaceuticals, Inc. to Host Earnings Call

Accesswire August 3, 2017

Ironwood Pharmaceuticals to Host Second Quarter 2017 Investor Update Call

Business Wire July 20, 2017

Ironwood Pharmaceuticals Reports Positive Top-line Results from IW-3718 Phase IIb Trial in Uncontrolled Gastroesophageal Reflux Disease

Business Wire July 20, 2017

Technical Reports on Generic Drugs Equities -- Allergan, Ironwood Pharma, Medicines Co., and Catalent

PR Newswire July 19, 2017